361 Capital’s Illumina ILMN Stock Holding History

361 Capital’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,376	Closed	-$416K	–	348
2019 Q1	$416K	Sell	1,376 -1,637	-54%	-$477K	0.07%	297
2018 Q4	$879K	Sell	3,013 -2,179	-42%	-$675K	0.18%	217
2018 Q3	$1.85M	Buy	+5,192	New	+$1.66M	0.4%	86

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

361 Capital's ILMN Position: Q2 2019 in Review

361 Capital sold out of Illumina (ILMN) in Q2 2019, closing a stake of 1,376 shares — an estimated $416K sold.

361 Capital first reported a position in ILMN in Q3 2018 and held it in 3 quarters. The position peaked at $1.85M in Q3 2018. 885 funds tracked by Wall St. Rank hold ILMN as of Q2 2019.

361 Capital reported no remaining Illumina position as of Q2 2019 after selling out during the quarter.
361 Capital sold 1,376 Illumina shares in Q2 2019, an estimated $416K.
361 Capital first reported a position in Illumina in Q3 2018 and held it in 3 quarters.
361 Capital's Illumina position peaked at $1.85M in Q3 2018.
885 funds tracked by Wall St. Rank held Illumina as of Q2 2019.

Based on 361 Capital's 13F filing for Q2 2019, filed 7 Aug 2019.